Palantir Technologies strengthens its position in industrial digital transformation and secure AI infrastructure through a broadened partnership with South Korea's HD Hyundai and a new role in developing sovereign AI data centers across Europe, the Middle East, and Africa.
Interparfums (IPAR) has locked in exclusive long-term licenses for the Nautica and David Beckham fragrance portfolios, aiming to revitalize the brands and expand their digital footprint globally. The deals signal a strategic push into mainstream lifestyle and celebrity scents.
Expedia Group's latest quarterly results, surpassing expectations across key metrics, have reignited investor interest and a fierce debate over its true worth. While analysts see room for growth, looming challenges in travel demand and disruptive AI search tools cloud the horizon.
Truist Financial taps debt markets with a multi-billion dollar issuance, aiming to strengthen its funding base while sustaining shareholder returns amidst a shifting interest rate landscape.
Standex International's fiscal Q2 results showcase robust organic growth and record order intake, driven by a multi-year strategic pivot towards new product innovation and high-growth markets like grid infrastructure and defense.
Orchid Island Capital (ORC) reported robust fourth-quarter earnings, driven by a stable interest rate environment, tightening mortgage spreads, and lower funding costs. The REIT continued its strategic pivot into higher-coupon mortgage pools with built-in prepayment protection.
Chemical and ammunition manufacturer Olin Corporation reported fourth-quarter results that missed internal forecasts, pressured by plant disruptions, supply issues, and a sharp year-end drop in chlorine demand. Executives emphasized cash preservation and cost control while navigating what they term an extended market downturn.
As FactSet's stock price fell 45% over the past year, investment firm McDonald Capital Investors made a significant $24 million purchase, underscoring a long-term conviction in the financial data provider's resilient, high-margin subscription business.
Novo Nordisk's newly launched oral GLP-1 drug, amycretin, has seen explosive initial demand in the U.S., potentially setting the stage for a significant financial turnaround and stock rally after a challenging previous year.
Verizon shares surged nearly 12% after quarterly results and guidance exceeded expectations, highlighting robust subscriber gains and a massive new share repurchase program aimed at rewarding investors.
Ontario's regulated online gambling sector capped a record-breaking year with a strong December performance, generating over $425 million in monthly revenue and pushing the annual total past the $4 billion mark, as the province's market continues to outpace growth seen in many U.S. states.
FTAI Aviation Ltd. has captivated investors with a staggering 167% surge, driven by explosive revenue growth and a unique hybrid model. But with a sky-high valuation, the market debates whether this aviation equipment leader is poised for a smooth cruise or facing turbulent air ahead.
Once a high-flying cloud communications leader, Five9 now trades at distressed valuations. With new leadership, activist investors circling, and a deep enterprise footprint, bulls see a prime candidate for a strategic rerating or acquisition.
Despite a new U.S. framework for involvement, extracting Greenland's rare earth metals is hampered by Arctic extremes, local political opposition, and strained transatlantic ties.
Despite political pressure and vast reserves, U.S. oil majors ExxonMobil and Chevron are taking a cautious stance on new spending in Venezuela, demanding legal stability and fiscal reforms before committing fresh capital, even as they signal long-term interest.
Amidst a challenging macro landscape, telecom operator VEON Ltd. is posting robust growth in its core frontier markets while aggressively expanding its digital ecosystem. With a valuation significantly below peers, analysts are debating whether the market is overlooking a hidden gem or rightly pricing in geopolitical risks.
Merck & Co. shifts its cancer drug development playbook, opting for targeted collaborations with Guardant Health and Eikon Therapeutics after walking away from a major acquisition. Analysts debate whether the stock's current price fully reflects its long-term pipeline potential.
Tetra Tech's stock has surged following strong Q1 results, raised guidance, and enhanced capital returns. While analysts see further upside, questions linger over contract risks and a premium valuation.
Viasat shares have rocketed 31% in a month, reigniting investor debate over whether the satellite communications firm is a hidden gem or a momentum-driven play facing stiff competition from SpaceX's Starlink and Amazon's Project Kuiper.
Marketing technology firm Zeta Global announces a strategic collaboration with OpenAI, aiming to deeply integrate advanced AI into its platform. The move, coupled with positive buzz from CES 2026, sharpens its competitive edge in a sector dominated by giants like Salesforce and Adobe.
